Optimizing the duration of anticoagulation therapy for venous thrombosis.
Solymoss
S
S
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants